At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Dexmedetomidine 1mcg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep
In Brief
A clinical study evaluating Dexmedetomidine and Zolpidem for Insomnia. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether dexmedetomidine can be used to induce normal physiological sleep in humans.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInsomnia
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH)
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedDec 2011
Enrollment StartJan 2015
Primary CompletionJan 2018
Study CompletionJun 2018
TodayJul 2026
First PostedDec 5, 2011
Enrollment StartJan 1, 2015
Primary CompletionJan 29, 2018
Study CompletionJun 29, 2018
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 14.6 years ago
Interventions
Dexmedetomidinedrug
A dose of dexmedetomidine will be administered at 1mcg/kg over 10 minutes. Subjects will never receive active drugs (Zolpidem or dexmedetomidine concurrently).
Zolpidemdrug
12.5 mg of oral Ambien CR. Subjects will never receive active drugs (Zolpidem/Ambien or dexmedetomidine concurrently).